Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Robert P. Rehfuss"'
Autor:
Patrick Y.S. Lam, John Lloyd, Ming Chang, Qimin Wu, Joanna Zheng, Robert P. Rehfuss, James C. Sutton, Christine Huang, Ji Hua, Laura Price, Zulan Pi, Ruth R. Wexler
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:4206-4209
ADP receptors, P2Y1 and P2Y12 have been recognized as potential targets for antithrombotic drugs. A series of P2Y1 antagonists that contain 2-aminothiazoles as urea surrogates were discovered. Extensive SAR of the thiazole ring is described. The most
Autor:
Laura Price, Ruth R. Wexler, Patrick Y.S. Lam, Pancras C. Wong, Dietmar A. Seiffert, Ming Chang, Joanna Zheng, Earl J. Crain, Robert P. Rehfuss, Carol A. Watson, Tammy C. Wang, Gerry Everlof, William A. Schumacher, Christine Huang, Charles G. Clark, Qimin Wu, Anne B. Stewart, Jeffrey S. Bostwick, Jennifer X. Qiao, Ji Jua
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:3239-3243
Preclinical data suggests that P2Y1 antagonists, such as diarylurea compound 1, may provide antithrombotic efficacy similar to P2Y12 antagonists and may have the potential of providing reduced bleeding liabilities. This manuscript describes a series
Autor:
Michael A. Poss, Ming Chang, Dora M. Schnur, Timothy F. Herpin, Ruth R. Wexler, Jacques Y. Roberge, Maredith Arcuri, Robert P. Rehfuss, Deborah Celani, Yalei Liu, Huji Turdi, Angela Cacace, Christine Huang, William A. Schumacher, Martin L. Ogletree, Hannguang Chao, Qimin Wu, Anne B. Stewart, Ji Hua, R. Michael Lawrence, Jeffrey S. Bostwick, Thomas E. Steinbacher, Laura Price, Lynn M. Abell
Publikováno v:
Journal of Medicinal Chemistry. 56:1704-1714
Two distinct G protein-coupled purinergic receptors, P2Y1 and P2Y12, mediate ADP-driven platelet activation. The clinical effectiveness of P2Y12 blockade is well established. Recent preclinical data suggest that P2Y1 and P2Y12 inhibition provide equi
Autor:
Pancras C. Wong, William A. Schumacher, Ji Hua, Earl J. Crain, Robert P. Rehfuss, Carol A. Watson
Publikováno v:
Thrombosis and Haemostasis. 101:108-115
SummaryThe new P2Y12 antagonist prasugrel produces greater inhibition of ADP-induced platelet aggregation (IPA) and reduction of thrombotic events in patients versus approved doses of clopidogrel, but increases major bleeding. We examined whether IPA
Autor:
Steven Grant, Suzanne J. Suchard, Robert P. Rehfuss, Steven G. Nadler, Kathleen M. Gillooly, Anish Suri, Robert Kuhn, Ruth Brosius, Yifan Zhang, Rathna Ravishankar, Kathy A Mink, Aaron P. Yamniuk, Sandra Rex-Rabe, Jenny Xie, Philip Drew, Luisa Salter-Cid, Kimberly S Waggie, James William Bryson, Olga Ignatovich, Lin Cheng, Laura Price, Xiadi Zhou, Yongmi An, James K. Tamura, Virna Borowski, Xiaoxia Yang, Bozena Abramczyk, Vojkan Susulic
Publikováno v:
Journal of immunology (Baltimore, Md. : 1950). 192(9)
CD40–CD40L interactions play a critical role in regulating immune responses. Blockade of CD40L by Abs, such as the anti-CD40L Ab 5c8, demonstrated positive clinical effects in patients with autoimmune diseases; however, incidents of thromboembolism
Autor:
Robert P. Rehfuss, John H. White, Sarah Bevan, Geoffrey N. Hendy, Damian G. Wheeler, Lucie Canaff, Andrew J. Mouland
Publikováno v:
Endocrinology. 139:1184-1196
Chromogranin A (CgA), a member of the granin/secretogranin family of acidic glycoproteins that play multiple roles in the process of regulated secretion of peptide hormones and neurotransmitters, is specifically expressed in endocrine and neuroendocr
Autor:
Robert P. Rehfuss, Paul Levesque, Juliang Zhu, Arvind Mathur, Dietmar A. Seiffert, Bang-Chi Chen, Rejean Ruel, Laura Price, Yufeng Wang, Mary F. Malley, Xue-Qing Chen, Wu Yang, Ji Hua, Tammy C. Wang, William A. Schumacher, Yajun Liu, Dauh-Rurng Wu, Silvi A. Chacko, Jeffrey S. Bostwick, Charles G. Clark, Danshi Li, Patrick Y.S. Lam, Henry S. Wong, Anne B. Stewart, Dawn Sun, Ruth R. Wexler, Hong Shen, Sheldon Hiebert, Christine Huang, Ling Li, Jeon Yoon T, Carl Thibeault, Jennifer X. Qiao
Publikováno v:
Bioorganicmedicinal chemistry letters. 24(5)
Spiropiperidine indoline-substituted diaryl ureas had been identified as antagonists of the P2Y1 receptor. Enhancements in potency were realized through the introduction of a 7-hydroxyl substitution on the spiropiperidinylindoline chemotype. SAR stud
Autor:
Carl Thibeault, Ruth R. Wexler, Dora M. Schnur, John Lloyd, Zulan Pi, Rejean Ruel, Patrick Y.S. Lam, William A. Schumacher, Ji Hua, Jennifer X. Qiao, Patricia A. McDonnell, Lynn M. Abell, Ming Chang, Christine Huang, Laura Price, Qi Gao, Robert P. Rehfuss, Baoqing Ma, Gilles Bouthillier, Eddie C.-K. Liu, Jeffrey S. Bostwick, Tammy C. Wang, Qimin Wu, Alexandre L'Heureux, Steven A. Spronk, Sheldon Hiebert, Joanna Zheng, Thomas E. Steinbacher
Publikováno v:
Journal of medicinal chemistry. 56(22)
Preclinical antithrombotic efficacy and bleeding models have demonstrated that P2Y1 antagonists are efficacious as antiplatelet agents and may offer a safety advantage over P2Y12 antagonists in terms of reduced bleeding liabilities. In this article,
Autor:
Qimin Wu, Alexandre L'Heureux, Christine Huang, Ji Hua, Robert P. Rehfuss, Jennifer X. Qiao, Laura Price, Patrick Y.S. Lam, Ming Chang, Ruth R. Wexler, Philippe Lapointe, Rejean Ruel, Alain Martel, Joanna Zheng, Carl Thibeault
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(24)
A number of new amine scaffolds with good inhibitory activity in the ADP-induced platelet aggregation assay have been found to be potent antagonists of the P2Y1 receptor. SAR optimization led to the identification of isoindoline 3c and piperidine 4a
Autor:
Patrick Y.S. Lam, Jean-Paul Daris, Carl Thibeault, Ruth R. Wexler, Ji Hua, Robert P. Rehfuss, Qimin Wu, Alexandre L'Heureux, Alain Martel, Rejean Ruel, Laura Price
Publikováno v:
Bioorganicmedicinal chemistry letters. 23(12)
Five-membered-ring heterocyclic urea mimics have been found to be potent and selective antagonists of the P2Y1 receptor. SAR of the various heterocyclic replacements is presented, as well as side-chain SAR of the more potent thiadiazole ring system w